Konstantina Papanastasiou
Aristotle University of Thessaloniki, GreecePresentation Title:
Efficacy and safety of spirulina in patients with mild dementia: One year single-blind randomized clinical trial
Abstract
Background: Spirulina is introduced as a dietary supplement with emerging neuroprotective properties, setting the stage for its potential application in neurodegenerative conditions like dementia.
Objective: To investigate for the first time the impact of Spirulina in combination with Mediterranean Diet (MeDi) in people with mild Dementia (mD).
Methods:
- Study Design: A randomized prospective trial
- Participants: Individuals with mild dementia, with some being APOE4 carriers, a genetic risk factor for Alzheimer’s disease.
- Intervention: Participants were divided into groups, with one receiving Spirulina alongside the MeDi and another group not receiving Spirulina.
- Assessments: Neuropsychological tests were administered at baseline and after 12 months. MRI and EEG were employed in some cases to confirm diagnoses.
Results: Statistical analysis was conducted using SPSS statistical software. The study found significant improvement in cognitive function for the Spirulina group compared to the control group.
Conclusion: While long-term Spirulina supplementation in conjunction with MeDi indicated substantial cognitive benefits, the study highlights the need for further research to explore this combination's potential.
Keywords: Mild Dementia, Spirulina, Neuroprotective, Mediterranean Diet
Biography
TBA